Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP
Clinical trial NCT00076037 · COMPLETED
Trial details
- NCT number
- NCT00076037
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.